Plakous Therapeutics

Plakous Therapeutics is a pre-clinical company developing a biotherapeutic platform for the treatment of rare pediatric diseases. Plakous' lead drug candidate for Necrotizing Enterocolitis (NEC) has received both a Rare Pediatric Disease and Orphan Drug designations from the FDA.